Benzingaยท2025-09-19 11:01Core Insights - The health care sector has several oversold stocks that present buying opportunities for undervalued companies [1] - The Relative Strength Index (RSI) is a key indicator for identifying oversold conditions, typically below 30 [1] Company Summaries - Boston Scientific Corp (BSX): Upgraded from Perform to Outperform by Oppenheimer analyst Steven Lichtman, with a price target raised from $118 to $125. The stock has a 52-week low of $80.64 and an RSI value of 27.3. Recent price action shows a 0.3% decline, closing at $98.23 [7] - aTyr Pharma Inc (ATYR): Announced that its Phase 3 EFZO-FIT study did not meet its primary endpoint, leading to an 80% stock decline over five days. The stock has a 52-week low of $0.97 and an RSI value of 22.6. Recent price action shows a 2.4% gain, closing at $1.05 [7] - Reviva Pharmaceuticals Holdings Inc (RVPH): Announced a $9 million public offering, resulting in a 21% decline over the past month. The stock has a 52-week low of $0.30 and an RSI value of 24.5. Recent price action shows a 3.7% gain, closing at $0.42 [7]